GLABF (Gemina Laboratories) EV-to-EBITDA : -13.30 (As of Jan. 19, 2025)

Gemina Laboratories EV-to-EBITDA Chart

Gemina Laboratories Quarterly Data
	Apr21	Jul21	Oct21	Jan22	Apr22	Jul22	Oct22	Jan23	Apr23	Jul23	Oct23	Jan24	Apr24	Jul24	Oct24
EV-to-EBITDA	Get a 7-Day Free Trial										-5.79	-8.14	-9.08	-8.76	-8.71

Competitive Comparison of Gemina Laboratories's EV-to-EBITDA

For the Biotechnology subindustry, Gemina Laboratories's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Gemina Laboratories's EV-to-EBITDA Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Gemina Laboratories's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Gemina Laboratories's EV-to-EBITDA falls into.

Gemina Laboratories EV-to-EBITDA Calculation

Gemina Laboratories's EV-to-EBITDA for today is calculated as:

Gemina Laboratories's current Enterprise Value is $33.74 Mil.
Gemina Laboratories's EBITDA for the trailing twelve months (TTM) ended in Oct. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-2.54 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Gemina Laboratories  (OTCPK:GLABF) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

Gemina Laboratories's PE Ratio (TTM) for today is calculated as:

Gemina Laboratories's share price for today is $0.5462.
Gemina Laboratories's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Oct. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.028.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio (TTM).

Please read Which price ratio outperforms the enterprise multiple?

Gemina Laboratories EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Gemina Laboratories's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.

Gemina Laboratories Business Description